Arrowstreet Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,778
| Closed | -$129K | – | 1567 |
|
|
2023
Q3 | $129K | Buy |
+29,778
| New | +$129K | ﹤0.01% | 1213 |
|
|
2022
Q2 | – | Sell |
-101,763
| Closed | -$1.15M | – | 1443 |
|
|
2022
Q1 | $1.15M | Sell |
101,763
-162,766
| -62% | -$1.84M | ﹤0.01% | 910 |
|
|
2021
Q4 | $4.15M | Sell |
264,529
-77,714
| -23% | -$1.22M | 0.01% | 859 |
|
|
2021
Q3 | $5.87M | Sell |
342,243
-79,179
| -19% | -$1.36M | 0.01% | 897 |
|
|
2021
Q2 | $9.07M | Buy |
+421,422
| New | +$9.07M | 0.01% | 870 |
|
|
2019
Q2 | – | Sell |
-52,559
| Closed | -$967K | – | 1724 |
|
|
2019
Q1 | $967K | Buy |
+52,559
| New | +$967K | ﹤0.01% | 1328 |
|
|
2017
Q2 | – | Sell |
-86,389
| Closed | -$1.21M | – | 1350 |
|
|
2017
Q1 | $1.21M | Buy |
+86,389
| New | +$1.21M | ﹤0.01% | 930 |
|
|
2013
Q4 | – | Sell |
-13,044
| Closed | -$143K | – | 1301 |
|
|
2013
Q3 | $143K | Buy |
+13,044
| New | +$143K | ﹤0.01% | 940 |
|